Jump to content

Paul Edwards

Recommended Posts

Currently the Pharmaceutical Benefits Scheme provides that Abiraterone  (Brand name Zytiga) must be taken with prednisone or prednisolone.


At its March 2017 meeting the PBAC approved an application that whilst Abiraterone must be taken with a corticosteroid, the corticosteroid does not necessarily have to be prednisone or prednisolone.  


Patients and their doctors are now able to choose the corticosteroid that they use with Abiraterone.  There has been evidence that corticosteroids other than prednisone or prednisolone may have less side effects or greater benefits. 

Link to comment
Share on other sites

  • Admin locked this topic


This topic is now archived and is closed to further replies.

This topic is now closed to further replies.
  • Create New...